P Chedraui1, F R Pérez-López2, G S Escobar3, J A Espinoza-Caicedo3, M Montt-Guevara4, A R Genazzani4, T Simoncini4. 1. Institute of Biomedicine, Research Area for Women's Health, Facultad de Ciencias Médicas, Universidad Católica de Santiago de Guayaquil, PO BOX 09-01-4671, Guayaquil, Ecuador. peter.chedraui@cu.ucsg.edu.ec. 2. Department of Obstetrics and Gynecology, Facultad de Medicina, Lozano Blesa University Hospital, Universidad de Zaragoza, Zaragoza, Spain. 3. Institute of Biomedicine, Research Area for Women's Health, Facultad de Ciencias Médicas, Universidad Católica de Santiago de Guayaquil, PO BOX 09-01-4671, Guayaquil, Ecuador. 4. Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Abstract
OBJECTIVE: To determine the prevalence of three single nucleotide polymorphisms (SNPs) in postmenopausal women with and without the metabolic syndrome (METS) and to explore levels of circulating biomarkers of inflammation, vascular and metabolic dysfunction according to SNP genotypes. METHODS: DNA was extracted from the whole blood of 192 natural postmenopausal women (40 to 65 years) screened for the METS and tested for three gene SNPs related to obesity: the fat mass obesity (FTO: rs9939609) and the methylenetetrahydrofolate reductase (MTHFR: C677T and A1298C). Blood levels of angiopoietin, IL-8, sFASL, IL-6, TNF-α, sCD40L, PAI-1, u-PA, leptin, adiponectin, resistin, ghrelin, visfatin, adipsin and insulin were measured in a subgroup, with and without the METS, using multiplex technology (n = 100) and compared according to SNP genotypes. RESULTS: Genotype frequency of the three studied SNPs did not differ in relation to the presence of the METS. However, genotypes CT+TT (C677T) and AT (rs9939609) were more prevalent in women with high triglyceride levels. Pooled sub-analysis (n = 100) found that median sCD40L and visfatin levels were higher in women with genotypes AT+TT (rs9939609) as compared to AA (1178 vs. 937.0 pg/mL and 0.93 vs. 0.43 ng/mL, respectively, p < 0.05). CONCLUSION: Two SNP genotypes related to obesity were more prevalent in women with abnormal triglyceride levels and two vascular and inflammatory serum markers were higher in relation to the rs9939609 SNP.
OBJECTIVE: To determine the prevalence of three single nucleotide polymorphisms (SNPs) in postmenopausal women with and without the metabolic syndrome (METS) and to explore levels of circulating biomarkers of inflammation, vascular and metabolic dysfunction according to SNP genotypes. METHODS: DNA was extracted from the whole blood of 192 natural postmenopausal women (40 to 65 years) screened for the METS and tested for three gene SNPs related to obesity: the fat mass obesity (FTO: rs9939609) and the methylenetetrahydrofolate reductase (MTHFR: C677T and A1298C). Blood levels of angiopoietin, IL-8, sFASL, IL-6, TNF-α, sCD40L, PAI-1, u-PA, leptin, adiponectin, resistin, ghrelin, visfatin, adipsin and insulin were measured in a subgroup, with and without the METS, using multiplex technology (n = 100) and compared according to SNP genotypes. RESULTS: Genotype frequency of the three studied SNPs did not differ in relation to the presence of the METS. However, genotypes CT+TT (C677T) and AT (rs9939609) were more prevalent in women with high triglyceride levels. Pooled sub-analysis (n = 100) found that median sCD40L and visfatin levels were higher in women with genotypes AT+TT (rs9939609) as compared to AA (1178 vs. 937.0 pg/mL and 0.93 vs. 0.43 ng/mL, respectively, p < 0.05). CONCLUSION: Two SNP genotypes related to obesity were more prevalent in women with abnormal triglyceride levels and two vascular and inflammatory serum markers were higher in relation to the rs9939609 SNP.
Authors: Patrícia Napoleão; Maria do Céu Monteiro; Luís B P Cabral; Maria Begoña Criado; Catarina Ramos; Mafalda Selas; Ana Maria Viegas-Crespo; Carlota Saldanha; Miguel Mota Carmo; Rui Cruz Ferreira; Teresa Pinheiro Journal: Transl Res Date: 2015-07-30 Impact factor: 7.012
Authors: I Kowalska; M T Malecki; M Straczkowski; J Skupien; M Karczewska-Kupczewska; A Nikolajuk; M Szopa; A Adamska; N Wawrusiewicz-Kurylonek; S Wołczynski; J Sieradzki; M Gorska Journal: Diabetes Metab Date: 2009-07-21 Impact factor: 6.041
Authors: T M Barber; A J Bennett; C J Groves; U Sovio; A Ruokonen; H Martikainen; A Pouta; A-L Hartikainen; P Elliott; C M Lindgren; R M Freathy; K Koch; W H Ouwehand; F Karpe; G S Conway; J A H Wass; M-R Järvelin; S Franks; M I McCarthy Journal: Diabetologia Date: 2008-05-14 Impact factor: 10.122
Authors: Kathryn G Ewens; Michelle R Jones; Wendy Ankener; Douglas R Stewart; Margrit Urbanek; Andrea Dunaif; Richard S Legro; Angela Chua; Ricardo Azziz; Richard S Spielman; Mark O Goodarzi; Jerome F Strauss Journal: PLoS One Date: 2011-01-20 Impact factor: 3.240
Authors: Angelo Scuteri; Serena Sanna; Wei-Min Chen; Manuela Uda; Giuseppe Albai; James Strait; Samer Najjar; Ramaiah Nagaraja; Marco Orrú; Gianluca Usala; Mariano Dei; Sandra Lai; Andrea Maschio; Fabio Busonero; Antonella Mulas; Georg B Ehret; Ashley A Fink; Alan B Weder; Richard S Cooper; Pilar Galan; Aravinda Chakravarti; David Schlessinger; Antonio Cao; Edward Lakatta; Gonçalo R Abecasis Journal: PLoS Genet Date: 2007-07 Impact factor: 5.917